Ayurcann Holdings Corp. Logo

Ayurcann Holdings Corp.

AYURF

(1.5)
Stock Price

0,02 USD

-29.08% ROA

-290.46% ROE

-2.02x PER

Market Cap.

10.076.704,74 USD

35.35% DER

0% Yield

-15.36% NPM

Ayurcann Holdings Corp. Stock Analysis

Ayurcann Holdings Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ayurcann Holdings Corp. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.29x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (4%), which means it has a small amount of debt compared to the ownership it holds

3 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

4 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-76.03%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-56.4%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Ayurcann Holdings Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ayurcann Holdings Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Ayurcann Holdings Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ayurcann Holdings Corp. Revenue
Year Revenue Growth
2011 0
2012 0 0%
2013 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 7.633.656 100%
2022 11.553.604 33.93%
2022 9.385.992 -23.09%
2023 25.939.380 63.82%
2023 12.491.839 -107.65%
2024 23.221.512 46.21%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ayurcann Holdings Corp. Research and Development Expenses
Year Research and Development Expenses Growth
2011 0
2012 0 0%
2013 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ayurcann Holdings Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 0
2012 101.675 100%
2013 1.533.841 93.37%
2013 610.669 -151.17%
2014 411.268 -48.48%
2015 261.045 -57.55%
2016 324.339 19.51%
2017 209.435 -54.86%
2018 218.310 4.07%
2019 196.349 -11.18%
2020 0 0%
2021 2.457.246 100%
2022 3.404.308 27.82%
2022 5.508.352 38.2%
2023 5.706.724 3.48%
2023 5.726.276 0.34%
2024 5.111.500 -12.03%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ayurcann Holdings Corp. EBITDA
Year EBITDA Growth
2011 -6.800
2012 -101.675 93.31%
2013 -1.601.125 93.65%
2013 -520.474 -207.63%
2014 4.040.714 112.88%
2015 -249.472 1719.71%
2016 -335.072 25.55%
2017 -219.028 -52.98%
2018 -296.725 26.18%
2019 -257.097 -15.41%
2020 -244.780 -5.03%
2021 2.542.418 109.63%
2022 -3.308.876 176.84%
2022 -2.973.889 -11.26%
2023 689.540 531.29%
2023 -4.144.766 116.64%
2024 -953.280 -334.79%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ayurcann Holdings Corp. Gross Profit
Year Gross Profit Growth
2011 0
2012 0 0%
2013 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 4.626.717 100%
2022 3.499.720 -32.2%
2022 2.220.594 -57.6%
2023 9.198.088 75.86%
2023 3.679.667 -149.97%
2024 7.557.836 51.31%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ayurcann Holdings Corp. Net Profit
Year Net Profit Growth
2011 -6.800
2012 -101.675 93.31%
2013 -3.264.327 96.89%
2013 -469.972 -594.58%
2014 -4.380.827 89.27%
2015 -170.134 -2474.93%
2016 -313.606 45.75%
2017 -199.842 -56.93%
2018 -272.773 26.74%
2019 -222.817 -22.42%
2020 -236.942 5.96%
2021 -278.360 14.88%
2022 -4.202.740 93.38%
2022 -3.087.907 -36.1%
2023 -722.580 -327.34%
2023 -5.307.125 86.38%
2024 -3.086.488 -71.95%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ayurcann Holdings Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 0
2012 0 0%
2013 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ayurcann Holdings Corp. Free Cashflow
Year Free Cashflow Growth
2011 34.766
2012 -76.134 145.66%
2013 -4.171.241 98.17%
2013 -1.253.503 -232.77%
2014 -487.310 -157.23%
2015 -220.258 -121.25%
2016 -199.037 -10.66%
2017 -202.752 1.83%
2018 -257.439 21.24%
2019 -239.117 -7.66%
2020 -235.947 -1.34%
2021 -707.548 66.65%
2022 172.183 510.93%
2022 -312.713 155.06%
2023 708.173 144.16%
2023 -568.674 224.53%
2024 964.748 158.95%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ayurcann Holdings Corp. Operating Cashflow
Year Operating Cashflow Growth
2011 34.766
2012 -76.134 145.66%
2013 -706.326 89.22%
2013 -537.293 -31.46%
2014 -375.684 -43.02%
2015 -220.258 -70.57%
2016 -199.037 -10.66%
2017 -202.752 1.83%
2018 -257.439 21.24%
2019 -239.117 -7.66%
2020 -235.947 -1.34%
2021 -198.562 -18.83%
2022 198.537 200.01%
2022 -50.092 496.34%
2023 794.014 106.31%
2023 -271.299 392.67%
2024 1.372.947 119.76%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ayurcann Holdings Corp. Capital Expenditure
Year Capital Expenditure Growth
2011 0
2012 0 0%
2013 3.464.915 100%
2013 716.210 -383.78%
2014 111.626 -541.62%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 508.986 100%
2022 26.354 -1831.34%
2022 262.621 89.97%
2023 85.841 -205.94%
2023 297.375 71.13%
2024 408.199 27.15%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ayurcann Holdings Corp. Equity
Year Equity Growth
2011 93.200
2012 367.162 74.62%
2013 6.569.620 94.41%
2013 7.044.184 6.74%
2014 1.831.876 -284.53%
2015 1.558.973 -17.51%
2016 1.358.916 -14.72%
2017 1.159.074 -17.24%
2018 1.569.757 26.16%
2019 1.346.940 -16.54%
2020 1.109.998 -21.35%
2021 4.749.223 76.63%
2022 4.893.986 2.96%
2022 5.758.751 15.02%
2023 2.692.517 -113.88%
2023 2.622.320 -2.68%
2024 1.907.749 -37.46%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ayurcann Holdings Corp. Assets
Year Assets Growth
2011 138.386
2012 398.476 65.27%
2013 6.739.915 94.09%
2013 7.651.785 11.92%
2014 1.865.154 -310.25%
2015 1.582.961 -17.83%
2016 1.381.238 -14.6%
2017 1.178.093 -17.24%
2018 1.607.366 26.71%
2019 1.365.623 -17.7%
2020 1.128.271 -21.04%
2021 6.677.006 83.1%
2022 7.282.982 8.32%
2022 10.592.677 31.25%
2023 12.730.397 16.79%
2023 14.442.796 11.86%
2024 16.166.190 10.66%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ayurcann Holdings Corp. Liabilities
Year Liabilities Growth
2011 45.186
2012 31.314 -44.3%
2013 170.295 81.61%
2013 607.601 71.97%
2014 33.278 -1725.83%
2015 23.988 -38.73%
2016 22.322 -7.46%
2017 19.019 -17.37%
2018 37.609 49.43%
2019 18.683 -101.3%
2020 18.273 -2.24%
2021 1.927.783 99.05%
2022 2.388.996 19.31%
2022 4.833.926 50.58%
2023 10.037.880 51.84%
2023 11.820.476 15.08%
2024 14.258.442 17.1%

Ayurcann Holdings Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.1
Net Income per Share
-0.03
Price to Earning Ratio
-2.02x
Price To Sales Ratio
0.6x
POCF Ratio
4.46
PFCF Ratio
8.11
Price to Book Ratio
4.35
EV to Sales
0.47
EV Over EBITDA
-2.99
EV to Operating CashFlow
4.2
EV to FreeCashFlow
6.31
Earnings Yield
-0.49
FreeCashFlow Yield
0.12
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.08
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0.03
Income Quality
-0.45
ROE
-1.71
Return On Assets
-0.25
Return On Capital Employed
-3.97
Net Income per EBT
1
EBT Per Ebit
1.24
Ebit per Revenue
-0.12
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.33
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.09
Gross Profit Margin
0.33
Operating Profit Margin
-0.12
Pretax Profit Margin
-0.15
Net Profit Margin
-0.15

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.01
Free CashFlow per Share
0.01
Capex to Operating CashFlow
0.33
Capex to Revenue
0.04
Capex to Depreciation
0.77
Return on Invested Capital
-2.05
Return on Tangible Assets
-0.29
Days Sales Outstanding
110.02
Days Payables Outstanding
309.92
Days of Inventory on Hand
148.84
Receivables Turnover
3.32
Payables Turnover
1.18
Inventory Turnover
2.45
Capex per Share
0

Balance Sheet

Cash per Share
0,02
Book Value per Share
0,01
Tangible Book Value per Share
-0
Shareholders Equity per Share
0.01
Interest Debt per Share
0.01
Debt to Equity
0.35
Debt to Assets
0.04
Net Debt to EBITDA
0.86
Current Ratio
0.92
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
2234327
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.13
Average Receivables
0,01 Bil.
Average Payables
0,01 Bil.
Average Inventory
4217998.5
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ayurcann Holdings Corp. Dividends
Year Dividends Growth

Ayurcann Holdings Corp. Profile

About Ayurcann Holdings Corp.

Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers end-to-end outsourcing solutions, including extraction and refinement, bulk distillate oil sales, formulation and white label manufacturing, and fulfillment and distribution, as well as customized packaging solutions and inventory management services. It also provides medicinal cannabis, such as tincture, vapes, and topicals. In addition, the company operates Ayurcann marketplace, an online cannabis market for medical cannabis consumers. The company was founded in 2018 and is headquartered in Pickering, Canada.

CEO
Mr. Igal Sudman
Employee
0
Address
1080 Brock Road
Pickering, L1W 3X4

Ayurcann Holdings Corp. Executives & BODs

Ayurcann Holdings Corp. Executives & BODs
# Name Age
1 Mr. Raj Virk
Head of Quality & Compliance
70
2 Mr. Igal Sudman
Co-Founder, Corporate Secretary, Chief Executive Officer & Chairman
70
3 Mr. Buzaker Roman
Co-Founder, President, Chief Operating Officer & Director
70
4 Mr. Yisroel Zuchter
Chief Financial Officer
70

Ayurcann Holdings Corp. Competitors